Видео с ютуба Valneva

CEO Thomas Lingelbach comments on Valneva’s H1 2020 results

Томас Лингельбах, Вальнева | Вакцины, болезнь Лайма | E47

Pandemics & Antibiotic resistance (eng) - Björn Olsen. Valneva Update Sverige 7/4-20

Baisse des Taux US : Analysons Ensemble ! | Focus Valneva, Kering, Bolloré

Meet our People, Meet Valneva: Michael R. (German Language)

Ellen Shannon, PhD - US Head of Medical Affairs, Valneva

New tools against chikungunya: "A Moment With..." Dr Juan Carlos Jaramillo (Valneva)

Valneva, Novavax, BionTech Aktie jetzt kaufen? Impfstoff Aktien in der Analyse! Aktienanalyse 2022!

Analyse technique CAC 40 et Valneva- Apprendre le trading et Ichimoku [27/06/2014]

Valneva и Dynavax объединяют усилия для создания вакцины от коронавируса Стоит ли брать в портфель?

Témoignage employeur : VALNEVA 🎤

Pets at Home Up, Valneva Up, WPP Down | Stock Movers

Dax Erweiterung, Evergrande droht Insolvenz, Biontech und Valneva News | Markt Update

IXCHIQ Chikungunya Vaccine Trial Shows Sustained Immune Response in Adolescents

WTI, Gold, Moderna, Valneva (Chart-Checks)

$VALN Valneva SE H1 2025 Earnings Conference Call

FDA Approved Chikungunya Vaccine of Valneva, For At-Risk Adults | Vaccine Of Valneva। #shorts #fda

Valneva, Facebook, Paypal, Xiaomi | Börsenwoche Zusammengefasst

CEO Thomas Lingelbach Comments on Valneva's 2022 Half-Year Results

Novavax und Valneva Wirkverstärker und Nebenwirkungen